全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Recent Advances in Metabolomics and Therapeutics for Cancer Cachexia

DOI: 10.4236/jct.2023.141004, PP. 38-49

Keywords: Drug Discovery, Stable Isotopes, Muscle Wasting, Oncology

Full-Text   Cite this paper   Add to My Lib

Abstract:

Cancer Cachexia afflicts 50 - 80 percent of cancer patients with roughly 20 percent of all cancer patients dying of cachexia. Metabolomics is the study of different metabolites, their location in the body, and the timing of their appearance and disappearance. As a result, this science of Metabolomics can be applied to solve the problem of Cancer Cachexia. In this review, I examine recent studies on metabolism that use Metabolomics as their instrument of discovery. Further, this review details potential therapeutic interventions at the cellular, animal, and human level that show promise for attenuating Cancer Cachexia.

References

[1]  Lambert, C.P. (2021) Anti-Cachexia Therapy Should Target Metabolism, Inflammatory Cytokines, and Androgens in Hormone-Independent Cancers. Journal of Cachexia, Sarcopenia and Muscle, 12, 1352-1353.
https://doi.org/10.1002/jcsm.12762
[2]  Cala, M.P., Agullo-Ortuno, M.T., Prieto-Garcia, E., et al. (2018) Multiplatform Plasma Fingerprinting in Cancer Cachexia: A Pilot Observational and Translational Study. Journal of Cachexia, Sarcopenia and Muscle, 9, 348-357.
https://doi.org/10.1002/jcsm.12270
[3]  Pin, F., Barreto, R., Couch, M.E., et al. (2019) Cachexia Induced by Cancer and Chemotherapy Yield Distinct Perturbations to Energy Metabolism. Journal of Cachexia, Sarcopenia and Muscle, 10, 140-154.
https://doi.org/10.1002/jcsm.12360
[4]  Berg, J.M., Tymoczko, J.L., Gatto, G.J. and Stryer, L. (2019) Biochemistry. 9th Edition, Macmillan, New York.
https://doi.org/10.1007/978-3-662-54620-8
[5]  Wolfe RRC, D.L. (2004) Isotope Tracers in Metabolic Research: Principle and Practice of Kinetic Analysis. 2nd Edition, Wiley-Liss, Hoboken.
[6]  Liberti, M.V. and Locasale, J.W. (2016) The Warburg Effect: How Does It Benefit Cancer Cells? Trends in Biochemical Sciences, 41, 211-218.
https://doi.org/10.1016/j.tibs.2015.12.001
[7]  Viana, L.R., Tobar, N., Busanello, E.N.B., et al. (2019) Leucine-Rich Diet Induces a Shift in Tumour Metabolism from Glycolytic towards Oxidative Phosphorylation, Reducing Glucose Consumption and Metastasis in Walker-256 Tumour-Bearing Rats. Scientific Reports, 9, Article No. 15529.
https://doi.org/10.1038/s41598-019-52112-w
[8]  Chiocchetti, G.M.E., Lopes-Aguiar, L., Miyaguti, N., et al. (2021) A Time-Course Comparison of Skeletal Muscle Metabolomic Alterations in Walker-256 Tumour-Bearing Rats at Different Stages of Life. Metabolites, 11, 404.
https://doi.org/10.3390/metabo11060404
[9]  Kunz, H.E., Dorschner, J.M., Berent, T.E., et al. (2020) Methylarginine Metabolites Are Associated with Attenuated Muscle Protein Synthesis in Cancer-Associated Muscle Wasting. Journal of Biological Chemistry, 295, 17441-17459.
https://doi.org/10.1074/jbc.RA120.014884
[10]  Fell, R.D., McLane, J.A., Winder, W.W. and Holloszy, J.O. (1980) Preferential Resynthesis of Muscle Glycogen in Fasting Rats after Exhausting Exercise. American Journal of Physiology, 238, R328-R332.
https://doi.org/10.1152/ajpregu.1980.238.5.R328
[11]  Miyaguti, N., Chiocchetti, G.M.E., Salgado, C.M., et al. (2021) Walker-256 Tumour-Induced Cachexia Altered Liver Metabolomic Profile and Function in Weanling and Adult Rats. Metabolites, 11, 831.
https://doi.org/10.3390/metabo11120831
[12]  Viana, L.R., Lopes-Aguiar, L., Rossi Rosolen, R., et al. (2020) (1)H-NMR Based Serum Metabolomics Identifies Different Profile between Sarcopenia and Cancer Cachexia in Ageing Walker 256 Tumour-Bearing Rats. Metabolites, 10, 161.
https://doi.org/10.3390/metabo10040161
[13]  Katsanos, C.S., Kobayashi, H., Sheffield-Moore, M., Aarsland, A. and Wolfe, R.R. (2006) A High Proportion of Leucine Is Required for Optimal Stimulation of the Rate of Muscle Protein Synthesis by Essential Amino Acids in the Elderly. American Journal of Physiology-Endocrinology and Metabolism, 291, E381-E387.
https://doi.org/10.1152/ajpendo.00488.2005
[14]  Tseng, Y.C., Kulp, S.K., Lai, I.L., et al. (2015) Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. JNCI: Journal of the National Cancer Institute, 107, djv274.
https://doi.org/10.1093/jnci/djv274
[15]  Collier, K.A., Valencia, H., Newton, H., et al. (2021) A Phase 1 Trial of the Histone Deacetylase Inhibitor AR-42 in Patients with Neurofibromatosis Type 2-Associated Tumors and Advanced Solid Malignancies. Cancer Chemotherapy and Pharmacology, 87, 599-611.
https://doi.org/10.1007/s00280-020-04229-3
[16]  Shukla, S.K., Dasgupta, A., Mehla, K., et al. (2015) Silibinin-Mediated Metabolic Reprogramming Attenuates Pancreatic Cancer-Induced Cachexia and Tumor Growth. Oncotarget, 6, 41146-41161.
https://doi.org/10.18632/oncotarget.5843
[17]  Baracos, V.E. (2006) Cancer-Associated Cachexia and Underlying Biological Mechanisms. Annual Review of Nutrition, 26, 435-461.
https://doi.org/10.1146/annurev.nutr.26.061505.111151
[18]  Der-Torossian, H., Wysong, A., Shadfar, S., et al. (2013) Metabolic Derangements in the Gastrocnemius and the Effect of Compound A Therapy in a Murine Model of Cancer Cachexia. Journal of Cachexia, Sarcopenia and Muscle, 4, 145-155.
https://doi.org/10.1007/s13539-012-0101-7
[19]  Ballaro, R., Lopalco, P., Audrito, V., et al. (2021) Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia. Cancers (Basel), 13, 850.
https://doi.org/10.3390/cancers13040850
[20]  Lautaoja, J.H., Lalowski, M., Nissinen, T.A., et al. (2019) Muscle and Serum Metabolomes Are Dysregulated in Colon-26 Tumor-Bearing Mice despite Amelioration of Cachexia with Activin Receptor Type 2B Ligand Blockade. American Journal of Physiology-Endocrinology and Metabolism, 316, E852-E865.
https://doi.org/10.1152/ajpendo.00526.2018
[21]  Kelly, M.G., Alvero, A.B., Chen, R., et al. (2006) TLR-4 Signaling Promotes Tumor Growth and Paclitaxel Chemoresistance in Ovarian Cancer. Cancer Research, 66, 3859-3868.
https://doi.org/10.1158/0008-5472.CAN-05-3948
[22]  Franco-Trepat, E., Alonso-Perez, A., Guillan-Fresco, M., et al. (2022) Amitriptyline Blocks Innate Immune Responses Mediated by Toll-Like Receptor 4 and IL-1 Receptor: Preclinical and Clinical Evidence in Osteoarthritis and Gout. British Journal of Pharmacology, 179, 270-286.
https://doi.org/10.1111/bph.15707
[23]  Freire, P.P., Fernandez, G.J., de Moraes, D., et al. (2020) The Expression Landscape of Cachexia-Inducing Factors in Human Cancers. Journal of Cachexia, Sarcopenia and Muscle, 11, 947-961.
https://doi.org/10.1002/jcsm.12565
[24]  Hardee, J.P., Fix, D.K., Wang, X., et al. (2018) Systemic IL-6 Regulation of Eccentric Contraction-Induced Muscle Protein Synthesis. American Journal of Physiology-Cell Physiology, 315, C91-C103.
https://doi.org/10.1152/ajpcell.00063.2018
[25]  Bonetto, A., Aydogdu, T., Kunzevitzky, N., et al. (2011) STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia. PLOS ONE, 6, e22538.
https://doi.org/10.1371/journal.pone.0022538
[26]  Bonetto, A., Rupert, J.E., Barreto, R. and Zimmers, T.A. (2016) The Colon-26 Carcinoma Tumor-Bearing Mouse as a Model for the Study of Cancer Cachexia. Journal of Visualized Experiments, No. 117, 54893.
https://doi.org/10.3791/54893
[27]  Lang, C.H., Frost, R.A., Nairn, A.C., et al. (2002) TNF-Alpha Impairs Heart and Skeletal Muscle Protein Synthesis by Altering Translation Initiation. American Journal of Physiology-Endocrinology and Metabolism, 282, E336-E347.
https://doi.org/10.1152/ajpendo.00366.2001
[28]  Li, Y.P., Chen, Y., John, J., et al. (2005) TNF-Alpha Acts via p38 MAPK to Stimulate Expression of the Ubiquitin Ligase atrogin1/MAFbx in Skeletal Muscle. FASEB Journal, 19, 362-370.
https://doi.org/10.1096/fj.04-2364com
[29]  Zhou, L., Zhang, T., Shao, W., et al. (2021) Amiloride Ameliorates Muscle Wasting in Cancer Cachexia through Inhibiting Tumor-Derived Exosome Release. Skeletal Muscle, 11, 17.
https://doi.org/10.1186/s13395-021-00274-5
[30]  Lambert, C. (2022) Attenuating Cancer Cachexia-Prolonging Life. In: Frailty and Sarcopenia—Recent Evidence and New Perspectives, IntechOpen, London, 67-76.
https://doi.org/10.5772/intechopen.101250
[31]  Lambert, C.P. (2022) Resistance Exercise to Mitigate Cancer Cachexia: Molecular Mechanisms and Practical Applications. Journal of Cancer Therapy, 13, 497-506.
https://doi.org/10.4236/jct.2022.138044
[32]  Viana, L.R., Chiocchetti, G.M.E., Oroy, L., et al. (2021) Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats. Cells, 10, 3272.
https://doi.org/10.3390/cells10123272
[33]  Zhang, J., Ma, Y. and Li, W. (2022) Curcumin Reduces Inflammation in Mice with the Psoriasis Model by Inhibiting NLRP3 Inflammatory Bodies. Cellular and Molecular Biology (Noisy-le-grand), 67, 48-54.
https://doi.org/10.14715/cmb/2021.67.6.7
[34]  Penedo-Vazquez, A., Duran, X., Mateu, J., et al. (2021) Curcumin and Resveratrol Improve Muscle Function and Structure through Attenuation of Proteolytic Markers in Experimental Cancer-Induced Cachexia. Molecules, 26, 4904.
https://doi.org/10.3390/molecules26164904
[35]  Chaiworramukkul, A., Seetalarom, K., Saichamchan, S. and Prasongsook, N. (2022) A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Solid Cancer Patients. The Asian Pacific Journal of Cancer Prevention, 23, 2333-2340.
https://doi.org/10.31557/APJCP.2022.23.7.2333
[36]  Yang, H., Villani, R.M., Wang, H., et al. (2018) The Role of Cellular Reactive Oxygen Species in Cancer Chemotherapy. Journal of Experimental & Clinical Cancer Research, 37, 266.
https://doi.org/10.1186/s13046-018-0909-x
[37]  Zhou, L., Lu, R., Huang, C. and Lin, D. (2021) Taurine Protects C2C12 Myoblasts from Impaired Cell Proliferation and Myotube Differentiation under Cisplatin-Induced ROS Exposure. Frontiers in Molecular Biosciences, 8, Article ID: 685362.
https://doi.org/10.3389/fmolb.2021.685362
[38]  Temel, J.S., Abernethy, A.P., Currow, D.C., et al. (2016) Anamorelin in Patients with Non-Small-Cell Lung Cancer and Cachexia (ROMANA 1 and ROMANA 2): Results from Two Randomised, Double-Blind, Phase 3 Trials. The Lancet Oncology, 17, 519-531.
https://doi.org/10.1016/S1470-2045(15)00558-6
[39]  Argiles, J.M., Busquets, S., Stemmler, B. and Lopez-Soriano, F.J. (2014) Cancer Cachexia: Understanding the Molecular Basis. Nature Reviews Cancer, 14, 754-762.
https://doi.org/10.1038/nrc3829

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133